Brennan David R 4
4 · ALEXION PHARMACEUTICALS, INC. · Filed May 18, 2020
Insider Transaction Report
Form 4
Brennan David R
Director
Transactions
- Award
Common Stock, par value $.0001 per share
2020-05-14+3,468→ 15,109 total - Award
Common Stock, par value $.0001 per share
2020-05-14+2,428→ 17,537 total
Footnotes (2)
- [F1]Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest in their entirety on the earlier of (i) the first anniversary of the grant date and (ii) the date of the 2021 Annual Shareholder Meeting.
- [F2]Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest as to 25% on a quarterly basis. These Restricted Stock Units were issued in lieu of the annual cash retainer that the director was entitled to receive for service as a director.